Literature DB >> 36040264

Impact of the PEG length and PEGylation site on the structural, thermodynamic, thermal, and proteolytic stability of mono-PEGylated alpha-1 antitrypsin.

Xiao Liu1, Kobenan G W Kouassi1, Rita Vanbever1, Mireille Dumoulin2.   

Abstract

Conjugation to polyethylene glycol (PEG) is a widely used approach to improve the therapeutic value of proteins essentially by prolonging their body residence time. PEGylation may however induce changes in the structure and/or the stability of proteins and thus on their function(s). The effects of PEGylation on the thermodynamic stability can either be positive (stabilization), negative (destabilization), or neutral (no effect). Moreover, various factors such as the PEG length and PEGylation site can influence the consequences of PEGylation on the structure and stability of proteins. In this study, the effects of PEGylation on the structure, stability, and polymerization of alpha1-antitrypsin (AAT) were investigated, using PEGs with different lengths, different structures (linear or 2-armed) and different linking chemistries (via amine or thiol) at two distinct positions of the sequence. The results show that whatever the size, position, and structure of PEG chains, PEGylation (a) does not induce significant changes in AAT structure (either at the secondary or tertiary level); (b) does not alter the stability of the native protein upon both chemical- and heat-induced denaturation; and (c) does not prevent AAT to fully refold and recover its activity following chemical denaturation. However, the propensity of AAT to aggregate upon heat treatment was significantly decreased by PEGylation, although PEGylation did not prevent the irreversible inactivation of the enzyme. Moreover, conjugation to PEG, especially 2-armed 40 kDa PEG, greatly improved the proteolytic resistance of AAT. PEGylation of AAT could be a promising strategy to prolong its half-life after infusion in AAT-deficient patients and thereby decrease the frequency of infusions.
© 2022 The Protein Society.

Entities:  

Keywords:  PEGylation; alpha-1 antitrypsin (AAT); heat-induced aggregation; proteolysis; thermodynamic stability

Mesh:

Substances:

Year:  2022        PMID: 36040264      PMCID: PMC9375436          DOI: 10.1002/pro.4392

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.993


  70 in total

1.  Kinetic mechanism of protease inhibition by alpha1-antitrypsin.

Authors:  Un-Beom Kang; Je-Hyun Baek; Seung-Hyun Ryu; Joon Kim; Myeong-Hee Yu; Cheolju Lee
Journal:  Biochem Biophys Res Commun       Date:  2004-10-15       Impact factor: 3.575

2.  Kinetic and stoichiometric analysis of the modification process for N-terminal PEGylation of staphylokinase.

Authors:  Jun Wang; Tao Hu; Yongdong Liu; Guifeng Zhang; Guanghui Ma; Zhiguo Su
Journal:  Anal Biochem       Date:  2010-12-24       Impact factor: 3.365

3.  Inhibition of neutrophil elastase by alpha1-protease inhibitor at the surface of human polymorphonuclear neutrophils.

Authors:  Brice Korkmaz; Sylvie Attucci; Marie-Lise Jourdan; Luiz Juliano; Francis Gauthier
Journal:  J Immunol       Date:  2005-09-01       Impact factor: 5.422

4.  Criteria for selecting PEGylation sites on proteins for higher thermodynamic and proteolytic stability.

Authors:  Paul B Lawrence; Yulian Gavrilov; Sam S Matthews; Minnie I Langlois; Dalit Shental-Bechor; Harry M Greenblatt; Brijesh K Pandey; Mason S Smith; Ryan Paxman; Chad D Torgerson; Jacob P Merrell; Cameron C Ritz; Maxim B Prigozhin; Yaakov Levy; Joshua L Price
Journal:  J Am Chem Soc       Date:  2014-12-04       Impact factor: 15.419

5.  Helix stabilization of poly(ethylene glycol)-peptide conjugates.

Authors:  Amit Jain; Henry S Ashbaugh
Journal:  Biomacromolecules       Date:  2011-06-17       Impact factor: 6.988

6.  N-terminal mono-PEGylation of growth hormone antagonist: correlation of PEG size and pharmacodynamic behavior.

Authors:  Ling Wu; Sa V Ho; Wei Wang; Jianping Gao; Guifeng Zhang; Zhiguo Su; Tao Hu
Journal:  Int J Pharm       Date:  2013-06-21       Impact factor: 5.875

7.  Modulation of protein aggregation by polyethylene glycol conjugation: GCSF as a case study.

Authors:  Rahul S Rajan; Tiansheng Li; Mohini Aras; Christopher Sloey; Weston Sutherland; Hiromi Arai; Robert Briddell; Olaf Kinstler; Alexis M K Lueras; Yu Zhang; Heather Yeghnazar; Michael Treuheit; David N Brems
Journal:  Protein Sci       Date:  2006-04-05       Impact factor: 6.725

8.  PEGylated human plasma fibronectin is proteolytically stable, supports cell adhesion, cell migration, focal adhesion assembly, and fibronectin fibrillogenesis.

Authors:  Chen Zhang; Sogol Hekmatfar; Anand Ramanathan; Nancy W Karuri
Journal:  Biotechnol Prog       Date:  2013-03-06

Review 9.  The impact of PEGylation on biological therapies.

Authors:  Francesco M Veronese; Anna Mero
Journal:  BioDrugs       Date:  2008       Impact factor: 5.807

10.  In silico assessment of potential druggable pockets on the surface of α1-antitrypsin conformers.

Authors:  Anathe O M Patschull; Bibek Gooptu; Paul Ashford; Tina Daviter; Irene Nobeli
Journal:  PLoS One       Date:  2012-05-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.